Xiaoying Zhou
Impact in
- Aging top 2%
- Cell Biology top 1%
- Plant Pathogens and Fungal Diseases
Papers in
-
- Cancer, Hypoxia, and Metabolism 16
- Cancer-related molecular mechanisms research 9
- Aging 3
- Co-authors
- Jin‐Rong XuGuotian LiChenfang WangZhe ZhangHaifeng ZhangGregor B. AdamsWende LiuLingan Kong
- Journals
- PLoS ONE (8 papers)Stem Cell Research (5 papers)Frontiers in Oncology (5 papers)Frontiers in Immunology (4 papers)Stem Cells and Development (3 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Xiaoying Zhou
140 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Aging 101
- Cell Biology 791
- Plant Science 1.6k
- Molecular Biology 2.1k
- Endocrine and Autonomic Systems 201
Countries citing papers authored by Xiaoying Zhou
This map shows the geographic impact of Xiaoying Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Zhou more than expected).
Fields of papers citing papers by Xiaoying Zhou
This network shows the impact of papers produced by Xiaoying Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Zhou. The network helps show where Xiaoying Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoying Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | Hypoxia-tropic delivery of nanozymes targeting transferrin receptor 1 for nasopharyngeal carcinoma radiotherapy sensitization Hit paper breakdown → | 2025 | 22 |
| 3 | 2024 | 6 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 23 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 17 | |
| 14 | 2021 | 7 | |
| 15 | MiR-34a Inhibits Cell Proliferation and Induces Apoptosis in Human Nasopharyngeal Carcinoma by Targeting lncRNA MCM3AP-AS1 | 2020 | 1 |
| 16 | Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway | 2019 | 2 |
| 17 | 2019 | 25 | |
| 18 | 2016 | 1 | |
| 19 | 2016 | 3 | |
| 20 | 2016 | 2 |
About Xiaoying Zhou
Xiaoying Zhou is a scholar working on Cancer Research, Aging, Molecular Biology, Endocrine and Autonomic Systems and Cell Biology, having authored 149 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (16 papers), Fungal and yeast genetics research (13 papers), Epigenetics and DNA Methylation (13 papers), Plant-Microbe Interactions and Immunity (10 papers), Plant Pathogens and Fungal Diseases (10 papers), Cancer-related molecular mechanisms research (9 papers), Pluripotent Stem Cells Research (9 papers) and Renal and related cancers (9 papers). The work is most often cited by research in Aging (101 citations), Cell Biology (791 citations), Plant Science (1.6k citations), Molecular Biology (2.1k citations) and Endocrine and Autonomic Systems (201 citations). Xiaoying Zhou has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jin‐Rong Xu, Guotian Li, Chenfang Wang, Zhe Zhang, Haifeng Zhang, Gregor B. Adams, Wende Liu, Lingan Kong, Jay Dunlap and Guangwu Huang. Their work appears in journals such as PLoS ONE, Stem Cell Research, Frontiers in Oncology, Frontiers in Immunology and Stem Cells and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.